Jan Wehkamp
Impact in
- Microbiology top 0.05%
- Antimicrobial Peptides and Activities
- Immunology top 0.5%
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
Papers in
- Microbiology 74
- Antimicrobial Peptides and Activities 74
-
- Pediatric health and respiratory diseases 23
- Co-authors
- Eduard F. StangeKlaus FellermannSabine NudingCharles BevinsJürgen HarderMatthias SchwabMiriam SchleeKlaus Herrlinger
- Journals
- Gastroenterology (14 papers)Journal of Crohn s and Colitis (10 papers)Inflammatory Bowel Diseases (7 papers)Frontiers in Immunology (5 papers)Mucosal Immunology (5 papers)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
Jan Wehkamp
153 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Microbiology 2.9k
- Immunology 3.6k
- Gastroenterology 685
- Genetics 3.2k
- Emergency Medical Services 791
Countries citing papers authored by Jan Wehkamp
This map shows the geographic impact of Jan Wehkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Wehkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Wehkamp more than expected).
Fields of papers citing papers by Jan Wehkamp
This network shows the impact of papers produced by Jan Wehkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Wehkamp. The network helps show where Jan Wehkamp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Wehkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 30 | |
| 3 | 2023 | 1 | |
| 4 | 2019 | 19 | |
| 5 | 2018 | 15 | |
| 6 | 2018 | 8 | |
| 7 | 2016 | 124 | |
| 8 | 2013 | 12 | |
| 9 | 2013 | 33 | |
| 10 | 2012 | 328 | |
| 11 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Hit paper breakdown → | 2012 | 1156 |
| 12 | 2011 | 79 | |
| 13 | 2010 | 161 | |
| 14 | 2009 | 101 | |
| 15 | 2009 | 44 | |
| 16 | 2009 | 221 | |
| 17 | 2008 | 15 | |
| 18 | 2007 | 220 | |
| 19 | 2006 | 32 | |
| 20 | Reduced Paneth cell α-defensins in ileal Crohn's disease Hit paper breakdown → | 2005 | 749 |
About Jan Wehkamp
Jan Wehkamp is a scholar working on Microbiology, Emergency Medical Services, Immunology, Genetics and Food Science, having authored 159 papers that have together received 11.2k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (74 papers), Inflammatory Bowel Disease (45 papers), Probiotics and Fermented Foods (32 papers), Immune Response and Inflammation (28 papers), Pediatric health and respiratory diseases (23 papers), Gut microbiota and health (20 papers), Infant Nutrition and Health (19 papers) and Helicobacter pylori-related gastroenterology studies (16 papers). The work is most often cited by research in Microbiology (2.9k citations), Immunology (3.6k citations), Gastroenterology (685 citations), Genetics (3.2k citations) and Emergency Medical Services (791 citations). Jan Wehkamp has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Eduard F. Stange, Klaus Fellermann, Sabine Nuding, Charles Bevins, Jürgen Harder, Matthias Schwab, Miriam Schlee, Klaus Herrlinger, Michael Gersemann and Maureen J. Ostaff. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, Frontiers in Immunology and Mucosal Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.